Argireline in Treatment of Periorbital Wrinkles
Studying: Wrinkles · NCT01381484
About this trial
The purpose of this study is to determine whether La Jolie gel is effective in the treatment of periorbital wrinkles.
Argireline clinical trials
ClinicalTrials.gov lists 3 registered trials of Argireline: 0 recruiting or about to, 0 running, 2 completed, 1 in phase 3, 1 with results posted. The largest is Argireline in Treatment of Periorbital Wrinkles (70 people).
3registered trials
0recruiting now
0running
2completed
1in phase 3
1with results posted
- Completed 2
- Stopped or withdrawn 1
Where Argireline is in testing
Registered trials by phase. Phase 3 trials are the large ones that decide approval.
0Early phase 1First doses in people
0Phase 1Safety and dosing
1Phase 2Does it work?
1Phase 3Large confirmatory trials
0Phase 4After approval
1Not phasedObservational and other
Timeline
Each bar runs from a trial's start to its planned end; faded bars have no end date. Click a bar to open the trial.
Completed 2
Topical Acetyl Hexapeptide-8 and the Cosmetic Appearance of Oily Skin
Studying: Oily Skin · NCT02597777
About this trial
This is a randomized double-blinded study examining the effect of topical Acetyl Hexapeptide-8 AH8) for improving the cosmetic appearance and experience of oily skin.
Stopped early or withdrawn 1
Acetyl Hexapeptide-8 for Blepharospasm
Studying: Focal Dystonia · NCT01750346
About this trial
Background: \- Blepharospasm is caused by excessive contraction of the muscles that close the eye. One treatment is botulinum neurotoxin (BoNT), which works by weakening those muscles. Like BoNT, acetyl hexapeptide-8 (AH-8) works to weaken the muscles, but is available as a skin cream. AH-8 is the active ingredient in a number of cosmetic creams used to treat wrinkles. Researchers thought that AH-8 cream could be used to treat blepharospasm, but the original dose studied was not very effective. They want to try a higher dose of AH-8 in a cream to see if it can be a more effective treatment. …
Registered trials include ones that haven't published results yet. Trials are matched on the compound's name and code names (Argireline, acetyl hexapeptide-3, acetyl hexapeptide-8) in the listed interventions.